Two PQT Medicines trainings for regulators
M
The PQT Medicines Annual Quality Assessment Training for regulators will take place from 9 to 12 June 2025.
A new HPV assay prequalified by WHO
IVD
On 27 March WHO prequalified one additional in vitro diagnostic, the
Active Pharmaceutical Ingredient (API) Prequalified
M
Nirmatrelvir manufactured by DongBang Future Tech & Life Co., Ltd.
PQT/MED: Expanded abridged prequalification pathways
M
According to WHO’s Procedure for prequalification of pharmaceutical products (TRS 961, Annex 10), “WHO recognizes the evaluation of relevant
38th Invitation of Active Pharmaceutical Ingredients (APIs)
M
The following API was added:
Lupin’s ethambutol 100 mg dispersible prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
S Kant’s pyridoxine 10 mg tabl prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list: